GlassScriptPhysician profile
Michael Tsinberg
NPI 1326212994
$11,705.88
in general payments reported to CMS, 2019-2025
18 companies · $836 in 2025
The $836 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,395 · 2020: $471 · 2022: $195 · 2023: $31.14 · 2024: $8,779 · 2025: $836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,515 · Travel and Lodging: $2,091 · Food and Beverage: $2,031 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,514.50 |
| Travel and Lodging | $2,091.28 |
| Food and Beverage | $2,030.88 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,740.46 | 2024 | |
| Stryker Corporation | $1,023.75 | 2022-2024 | 1788 |
| Allergan, INC. | $961.88 | 2019 | |
| Davol INC. | $810.80 | 2019-2020 | |
| Janssen Biotech, INC. | $145.66 | 2024 | Tremfya, Stelara |
| Madrigal Pharmaceuticals | $125.00 | 2025 | Rezdiffra |
| Ardelyx, INC. | $121.83 | 2025 | Ibsrela |
| Genzyme Corporation | $121.82 | 2025 | |
| Celltrion USA INC. | $113.02 | 2025 | Zymfentra |
| Ipsen Biopharmaceuticals, INC | $111.95 | 2025 | Iqirvo |
| Pfizer INC. | $102.86 | 2025 | |
| Lilly USA, LLC | $97.10 | 2025 | |
| Ethicon US, LLC | $75.37 | 2019-2025 | Enseal, Harmonic |
| Acell, INC. | $48.56 | 2019 | |
| Abbvie INC. | $38.39 | 2023-2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25.99 | 2022 | |
| Baxter Healthcare | $22.02 | 2019 | |
| Merck Sharp & Dohme LLC | $19.42 | 2025 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Tsinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.